<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530071</url>
  </required_header>
  <id_info>
    <org_study_id>CHA-CDD-101</org_study_id>
    <nct_id>NCT04530071</nct_id>
  </id_info>
  <brief_title>Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Phase 1/2a, Multi-center Clinical Trial for Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain Due to Lumbar Intervertebral Disc Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHABiotech CO., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHABiotech CO., Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate safety, tolerability, and efficacy of CordSTEM-DD&#xD;
      in patients with chronic low back pain due to lumbar intervertebral disc degeneration&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 28, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 25, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of treatment emergent adverse events during the study period</measure>
    <time_frame>28 days on Stage 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of treatment emergent adverse events during the study period</measure>
    <time_frame>12 months on Stage 2</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Chronic Low-back Pain</condition>
  <arm_group>
    <arm_group_label>CordSTEM-DD(0.7x10^7 cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tissuefill+saline+CordSTEM-DD(0.7x10^7 cells)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CordSTEM-DD(2.1x10^7 cells)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tissuefill+saline+CordSTEM-DD(2.1x10^7 cells)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CordSTEM-DD (0.7 x 10^7 cells)</intervention_name>
    <description>CordSTEM-DD (0.7 x 10^7 cells) on Stage 1</description>
    <arm_group_label>CordSTEM-DD(0.7x10^7 cells</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CordSTEM-DD (2.1 x 10^7 cells)</intervention_name>
    <description>CordSTEM-DD (2.1 x 10^7 cells) on Stage 1</description>
    <arm_group_label>CordSTEM-DD(2.1x10^7 cells)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or females at least 19 years and under 70 years of age&#xD;
&#xD;
          2. Have chronic low back pain for at least 6 months and failed 6 months of conservative&#xD;
             back pain care&#xD;
&#xD;
          3. Screening period low back pain of at least 40mm on a 100mm VAS scale&#xD;
&#xD;
          4. Screening period low back function of at least 30 on a 100-point ODI Questionnaire&#xD;
&#xD;
          5. A modified Pfirrmann score of 3, 4, 5 or 6 on MRI at the index disc&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. NIH Clinical Guidelines Body Mass Index (BMI)&gt;30 ㎏/m^2&#xD;
&#xD;
          2. Osteoporosis, as defined by dual-energy X-ray absorptiometry (DEXA) scan. A DEXA&#xD;
             T-score of ≤ -2.5 will exclude the subject&#xD;
&#xD;
          3. An average baseline morphine equivalent dose (MED) of &gt;75mg/day as determined by&#xD;
             e-diary entries during the screening period&#xD;
&#xD;
          4. Clinically significant nerve pain (e.g., chronic radiculopathy or neuropathy)&#xD;
&#xD;
          5. If female, pregnancy, or lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In-Bo Han</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHA Bundang Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>In-Bo Han</last_name>
    <phone>+82 31 780 5000</phone>
    <email>hanib@cha.ac.kr</email>
  </overall_contact>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 19, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

